Sugar-Sweetened Placebo Tablet for Diabetes Clinical Trial

These placebo tablets, formulated with over 10% sugar by dry weight, are used in blinded clinical trials for diabetes medications to mimic active treatments without therapeutic ingredients. They are put up in measured doses as per Chapter 30 note 4(e) and classified under 3006.93.20.00 due to their high sugar content and trial-specific packaging.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳China10.4%+7.5%17.9%
🇲🇽Mexico10.4%10.4%
🇨🇦Canada10.4%10.4%
🇩🇪Germany10.4%10.4%
🇯🇵Japan10.4%10.4%

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Lower: 10% vs 17.9%

If containing actual active pharmaceutical ingredients

Products with real medicaments for therapeutic use shift to Chapter 30 headings 3003/3004, excluding placebos.

2106.90.99Lower: 13.9% vs 17.9%

If not specifically for recognized clinical trials

Sugar-based preparations without clinical trial put-up in measured doses fall under food supplements in Chapter 21.

3006.93.10.00Lower: Free vs 17.9%

If sugar content is 10% or less by dry weight

Lower sugar placebos stay in 3006.93 but move to the subheading without the over-10% qualifier.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Obtain FDA approval for clinical trial materials and include IND documentation to prove 'recognized clinical trial' status

Conduct lab analysis to confirm sugar content exceeds 10% by dry weight to avoid reclassification to lower-sugar subheadings

Declare as placebos explicitly on entry to prevent confusion with actual medicaments under 3004